A Four-way Crossover Study of 3 Formulations of M207 With Intranasal Zolmitriptan in Healthy Volunteers

Conditions

• Migraine

Interventions

• DRUG: M207 3.8 mg "Sled" (two 1.9 mg patches made on a "Sled" coater, foil pouches)
• DRUG: M207 3.8 mg "MACAP" (two 1.9 mg patches made on a "MACAP" coater, foil cups)
• DRUG: M207 3.8 mg "MiniMac" (two 1.9 mg patches made on a "MiniMac" coater, foil cups
• DRUG: Zolmitriptan 2.5 mg/0.1 mL nasal spray [ZOMIG] single dose

Sponsor

Zosano Pharma Corporation